Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv Inc.

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Inotiv, with a price target of $5.00. Takkinen covers the He...

Lake Street Keeps Their Buy Rating on Inotiv (NOTV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inotiv (NOTV – Research Report) and Exagen (XGN – Re...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NOTV	$0.82	-3.89%	740.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NOTV	$0.82	-3.9%	740.47K
3
4
5
6

NOTV

NOTV

Dividend Overview

Get Inotiv Inc. Data in Excel

Get Inotiv Inc. Data in Excel